Tumor Testing, ctDNA Finds More Patients Eligible for Person

Concurrent circulating tumor DNA and tissue-based testing identified more patients eligible for personalized cancer care than either of the tests done alone.

Related Keywords

Justin Guinney , , Help Predict Lung Cancer Outcomes , Cancer Genomics , Tempus Therapeutics , News , Tumor , Next Generation Sequencing , Circulating Tumor Dna , Tumor Testing ,